Real-world outcomes in patients with unresected stage III non-small cell lung cancer

The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non–Small Cell Lung Cancer

(2018) Eric D. Miller et al.   Journal of Thoracic Oncology

Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment

(2017) Ethan Basch et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

(2017) Scott J. Antonia et al.   NEW ENGLAND JOURNAL OF MEDICINE

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

(2016) Peter Goldstraw et al.   Journal of Thoracic Oncology

Definitive and Adjuvant Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline

(2015) Andrea Bezjak et al.   JOURNAL OF CLINICAL ONCOLOGY

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

(2015) Jeffrey D Bradley et al.   LANCET ONCOLOGY

Early treatment discontinuation and switching in first-line metastatic breast cancer: the role of patient-reported symptom burden

(2014) Mark S. Walker et al.   BREAST CANCER RESEARCH AND TREATMENT

Cisplatin vs. carboplatin-based chemoradiotherapy in patients >65years of age with stage III non-small cell lung cancer

(2014) Nicole Ezer et al.   RADIOTHERAPY AND ONCOLOGY

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) J. Vansteenkiste et al.   ANNALS OF ONCOLOGY

Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patients

(2011) Mark S Walker et al.   Health and Quality of Life Outcomes

Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

(2011) W. J. Curran et al.   JNCI-Journal of the National Cancer Institute

Population-Based Estimates of Survival Benefit Associated with Combined Modality Therapy in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer

(2011) Amy J. Davidoff et al.   Journal of Thoracic Oncology

Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer

(2010) Anne Aupérin et al.   JOURNAL OF CLINICAL ONCOLOGY

Validation of the Patient Care Monitor (Version 2.0): A Review of System Assessment Instrument for Cancer Patients

(2010) Amy P. Abernethy et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

A retrospective study of quality of life in a community sample of patients with early stage breast cancer

(2009) Mark S. Walker et al.   BREAST CANCER RESEARCH AND TREATMENT

Use of the patient care monitor to screen for depression in adult cancer patients interviewed with the structured clinical interview for DSM-IV

(2009) Arthur C. Houts et al.   PSYCHO-ONCOLOGY

Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancer

(2009) Lee S. Schwartzberg et al.   SUPPORTIVE CARE IN CANCER